Clinical evaluation of cyanate in sickle cell anemia.
D000284:Administration, Oral; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D002386:Cataract / Q000139:chemically induced; D003485:Cyanates / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D009420:Nervous System / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced; D010108:Oxyhemoglobins / Q000378:metabolism
D001798:Blood Proteins; D003485:Cyanates; D010108:Oxyhemoglobins